First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence

Leptomeningeal metastasis (LM) from lung cancer has poor prognosis, and effective therapy has not been established. We present the case of a 54-year-old man with LM from lung adenocarcinoma harboring EGFR L858R point mutation, who received osimertinib as first-line therapy. He had previously undergo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int Cancer Conf J
Hlavní autoři: Ono, Yuki, Takada, Kazuki, Osoegawa, Atsushi, Kinoshita, Fumihiko, Oba, Taro, Tsukamoto, Shuichi, Tagawa, Tetsuzo, Oda, Yoshinao, Mori, Masaki
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797384/
https://ncbi.nlm.nih.gov/pubmed/33489707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00453-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky